KRT18 and neoplasm: Patients with CK18-positive tumours had significantly poorer DFS and OS than those with CK18-negative tumours (5-year DFS: 30.6% vs 65.8%, respectively, P<0.001, 5-year OS: 32.8% vs 68.4%, respectively, P<0.001) (Figure 4A).